Cassava Sciences to Shine at H.C. Wainwright Conference
Cassava Sciences to Shine at the H.C. Wainwright Conference
Cassava Sciences, Inc. (Nasdaq: SAVA), a promising biotechnology firm focusing on Alzheimer's disease, is set to present at the H.C. Wainwright 26th Annual Global Investment Conference. This key event will take place in New York, and the company aims to share insights on their innovative approaches to treating neurodegenerative conditions.
Key Presentation Details
At the conference, Rick Barry, Cassava's Executive Chairman, will engage in a thought-provoking 'fireside chat' with Vernon T. Bernardino, PhD., the Managing Director of Biotechnology Equity Research at H.C. Wainwright. This session promises to delve into the latest developments in the field and highlight Cassava's pivotal role in advancing Alzheimer’s treatment.
How to Participate in the Conference
Registered institutional investors have the opportunity to log on to the H.C. Wainwright conference website to request a meeting with the Cassava Sciences team. This interaction could provide valuable insights and foster connections among key players in the biotechnology sector.
Event Specifics
The conference is scheduled for:
Date: Monday, September 9
Time: 3:00 PM to 3:30 PM Eastern Time
Webcast Details
Participants can access a live webcast during the event through the “Investors” page on Cassava Sciences' website. An archived replay will be available for review for 90 days post-event, ensuring that everyone can catch up on the discussions.
About Cassava Sciences, Inc.
Cassava Sciences is dedicated to advancing the science of detecting and treating neurodegenerative diseases, with a specific emphasis on Alzheimer's disease. With a strong foundation in research, the company is working on novel solutions aimed at regulating a vital protein in the brain, which could vastly improve outcomes for patients suffering from these complex conditions.
Contact Information
For further information, Eric Schoen, Chief Financial Officer of Cassava Sciences, can be reached at (512) 501-2450 or via email at ESchoen@CassavaSciences.com. Eric is available to answer any inquiries regarding the company's initiatives and the upcoming conference presentation.
Frequently Asked Questions
What is the H.C. Wainwright Global Investment Conference?
The H.C. Wainwright Global Investment Conference is an annual event that gathers investors and companies from the biotechnology sector to share insights and foster investment opportunities.
Who will represent Cassava Sciences at the conference?
Rick Barry, the Executive Chairman of Cassava Sciences, will represent the company at the conference.
How can I watch the Cassava Sciences presentation?
The presentation will be available through a live webcast accessible on Cassava Sciences' “Investors” page, with a replay option for those who cannot attend in real time.
What is the focus of Cassava Sciences?
Cassava Sciences is focused on developing therapies for neurodegenerative diseases, particularly Alzheimer’s disease, by targeting key proteins in the brain.
How can investors connect with Cassava Sciences during the conference?
Registered institutional investors can log into the H.C. Wainwright conference website to request meetings with Cassava Sciences representatives.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Equature's 2024.3 Software Revolutionizes Public Safety Operations
- Leinco Technologies Inc. Expands Portfolio with QED Biosciences
- Jamie Foxx Brings Humor to BetMGM's 2024 Football Campaign
- Wipfli Unveils 2024 Annual Report Detailing Growth and Innovation
- Autonomous Cars Forecast: Growth to USD 43.44 Billion By 2032
- Investing Insights: Nvidia Versus Arm Holdings in AI Sector
- Agmatix Unveils RegenIQ: Revolutionizing Regenerative Agriculture
- BoomerangFX Expands Innovative Solutions in Asia and Latin America
- Costco to Expand with Four New Locations by End of 2024
- Bloomberg CityLab 2024: Global Mayors Gather in Mexico City
- BCFNJC's What We Heard Report from First Nations Justice Forum
- Asia Pacific Wireless Earphones Market Expected to Thrive
- Cork Packaging Market Expected to Hit USD 2.7 Billion Growth
- MICE Industry Expected to Reach $1,337 Billion by 2033
- Packaging Automation Market Growth Driven by E-commerce Boom
- Status of Audit for Aktsiaselts Silvano Fashion Group Revealed
- Tiny Traveler Unveils Advanced AI Baby Monitor for Parents
- Portable Projector Market Growth Projections: $2.1 Billion by 2029
- Celebrate the Festive Season at The Ocean Club, Bahamas
- Ethical AI Transformation: The P&C Insurance Industry's Role
- HomeSafe Alliance Achieves Milestone Of 100 Military Moves
- Xiaohongshu's Street Life Festival Draws Record Attendance and Engagement
- Starlight Children's Foundation Celebrates Childhood Cancer Month
- Sandals Resorts Partners with Leo Burnett for Creative Vision
- Drew Ysseldyke Elevated to President & CEO of Grand River Bank
Recent Articles
- Aker ASA Finalizes Aker BioMarine Feed Ingredients Deal
- UC Asset LP Announces Management-Driven Stock Buyback Plan
- Papaya Global Reinvents Payroll with Innovative Tech-First Solution
- VAST Resources Plc Announces Major Holdings Notification
- Charlamagne Tha God Supports Hope Center with Generous Donation
- Global NGS Sample Preparation Market Poised for Growth
- Florida Crystals® Marks Organic Month with Milestones and New Packaging
- Pente Networks Launches HyperCore Cloud on AWS Program
- John Ballantyne Joins Glucotrack Board to Advance Innovation
- Femasys Highlights Innovation at H.C. Wainwright Conference
- Cemat A/S Announcements of Managerial Transactions
- Flight Adventure Park Launches Annual 'Soar For A Cause' Event
- UMMC Partners with Fiducius for Financial Wellness Initiative
- STRATA Skin Sciences CEO to Speak at H.C. Wainwright Event
- Compass Therapeutics Engages Investors at Upcoming Events
- Denali Therapeutics Plans Accelerated Approval for DNL310
- Aspire Biopharma and PowerUp Combine to Innovate Drug Delivery
- NRx Pharmaceuticals and HOPE Therapeutics to Present at Conference
- Skyharbour Launches New Drilling Program at Moore Uranium Project
- Builtmore Contract Manufacturing Launches Isuzu NRR-EV Production
- iBio Leaders Set to Speak at Major Investor Conferences
- Probe Gold Achieves High-Grade Gold Intersections in Quebec
- Nvidia's Recent Earnings: Analyst Views and Market Reactions
- Symbotic Inc. Investors Alert: Class Action Lawsuit Notice
- U.S. Steel Shares Drop Amid Concerns Over Ownership Shift